Jon Wigginton
2017
In 2017, Jon Wigginton earned a total compensation of $1.5M as Senior Vice President, Clinical Development and Chief Medical Officer at MacroGenics, a 48% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $197,600 |
|---|---|
| Option Awards | $865,708 |
| Salary | $445,050 |
| Other | $8,100 |
| Total | $1,516,458 |
Wigginton received $865.7K in option awards, accounting for 57% of the total pay in 2017.
Wigginton also received $197.6K in non-equity incentive plan, $445.1K in salary and $8.1K in other compensation.
Rankings
In 2017, Jon Wigginton's compensation ranked 6,932nd out of 14,666 executives tracked by ExecPay. In other words, Wigginton earned more than 52.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,932 out of 14,666 | 53rd |
Division Manufacturing | 2,568 out of 5,768 | 56th |
Major group Chemicals And Allied Products | 830 out of 2,074 | 60th |
Industry group Drugs | 644 out of 1,730 | 63rd |
Industry Pharmaceutical Preparations | 506 out of 1,329 | 62nd |
Source: SEC filing on April 2, 2020.
Wigginton's colleagues
We found four more compensation records of executives who worked with Jon Wigginton at MacroGenics in 2017.